BioSpace News Archive

Blue Cross and Blue Shield of North Carolina (Blue Cross NC) and IPG, the industry-leading provider of surgical cost management solutions are pleased to announce an expansion of their agreement to lower surgical costs

Cidara Therapeutics Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations for the company’s prophylaxis (prevention) development program for lead antifungal product candidate, rezafungin for injection.

enatoRx Pharmaceuticals, Inc., a world leader in antibacterial and antiviral drug research and development, today announced that it entered into an exclusive license agreement (“License Agreement”) with Everest Medicines II Limited (“Everest”), a C-Bridge Capital-backed biopharmaceutical company with operations based in China, to support the development, registration and commercialization of cefepime/VNRX-5133 in Greater China, South Korea and Southeast Asia

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the initiation of PolarisDMD, the Company’s Phase 3 trial for edasalonexent in Duchenne muscular dystrophy (DMD).

pMD, the innovation leader in health care technology and avid supporter of the Medical Group Management Association (MGMA), will be participating as an exhibitor at this year’s MGMA Annual Conference in Boston, Massachusetts at the Boston Convention and Exhibition Center from September 30 through October 2.

A participant in Nordic Nanovector ASA’s (the “Company”) (OSE:NANO) previous employee share option program, not being a primary insider, has exercised a total number of 30,832 options through exercise of a corresponding number of free-standing warrants.

Appropriate patients can receive the only needle-free, nasal spray flu vaccine from physicians as soon as late September

Gaurav Shah, M.D., Chief Executive Officer, Invited as Panel Member at The Galien Forum USA 2018

Deciphera Pharmaceuticals, Inc. today announced that Michael Taylor, Ph.D., President and Chief Executive Officer, will present at the 2018 Cantor Global Healthcare Conference on Tuesday, October 2, 2018 at 4:00 PM ET at the InterContinental New York Barclay Hotel.

PellePharm today announced that Sanuj K. Ravindran, M.D., chief executive officer and president, will present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, October 2, at 4:35 p.m. ET in New York.